Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4862)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2025 (publication date) through Apr 25, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Wang YC, Zhang CG, Wang YW, Guo C, Pan T, Yu PJ, Cai BJ, Ding RH, Qiang JL, Deng CQ, Hu CH, Xu YH. SOX plus sintilimab vs P-SOX vs SOX as neoadjuvant therapy in advanced gastric cancer: Efficacy and safety. World J Gastrointest Oncol 2025; 17(8): 109646 [PMID: 40837776 DOI: 10.4251/wjgo.v17.i8.109646] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Wang YC, Zhang CG, Wang YW, Guo C, Pan T, Yu PJ, Cai BJ, Ding RH, Qiang JL, Deng CQ, Hu CH, Xu YH. SOX plus sintilimab vs P-SOX vs SOX as neoadjuvant therapy in advanced gastric cancer: Efficacy and safety. World J Gastrointest Oncol 2025; 17(8): 109646 [PMID: 40837776 DOI: 10.4251/wjgo.v17.i8.109646] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i8/109646.htm |
| Number | Citing Articles |
| 1 |
Shu-Cong Peng, Jing-Xiao Li, Kun-Lin He, Hua-Fu Zhou, Shang-Wei Chen, Jun Liu. Development and validation of a nomogram using transaminase levels, cycle cost, and hair loss as predictive factors for the response to neoadjuvant chemotherapy in esophageal cancer. Journal of Cardiothoracic Surgery 2026; 21(1) doi: 10.1186/s13019-026-03912-5
|
| 2 |
Nabil Ismaili. Shifting paradigm in locally advanced resectable gastric and gastroesophageal junction cancers. World Journal of Gastrointestinal Oncology 2026; 18(2): 113150 doi: 10.4251/wjgo.v18.i2.113150
|